QliniQ
QliniQ B.V. is a Dutch medical device and pharmaceutical distributor representing international manufacturers (VOE compression garments, Biodermis scar treatment, Stragen generics) for the Netherlands market through pharmacy wholesale, e-commerce, and insurance reimbursement channels.
- Company typePrivate
- Founded2015
- HeadquartersOldenzaal, Netherlands
- Headcount1–10
- GTM typeB2B
- OfferingServices
What QliniQ does
QliniQ B.V. is a Netherlands-based medical device and pharmaceutical distributor headquartered in Oldenzaal, operating since 2015 as the exclusive Dutch representative for several international manufacturers of medical devices and generic medicines (Stragen, VOE, Basic Pharma, CERES Pharma, Biodermis). The company's product portfolio spans three categories: VOE post-operative compression garments (including custom-made orders fulfilled through an in-house atelier and the VOE Slim shapewear line with embedded active ingredients); the Biodermis silicone scar treatment line (Xeragel silicone gel, Epiderm silicone sheets in multiple variants, and ProSil silicone gel stick); and generic pharmaceuticals distributed through Dutch pharmacies, including hormone tablets (Tibolon Mithra, Vagirux, Zarelle), topical preparations (Cortifil cream, Triamcinolone acetonide ointment), Dienogest Stragen, and the Fecotest diagnostic self-test. All distributed products are manufactured within the EU, primarily in the Netherlands, Germany, and Spain.
The company monetizes through wholesale pharmaceutical distribution to Dutch pharmacies under a pharmaceutical wholesale license and GDP certification held since January 2016, direct-to-consumer e-commerce sales of compression garments through its own webshop (postoperatievedrukkleding.nl), and insurance-reimbursed sales of Biodermis scar treatment products when prescribed by physicians with a Zorgverzekeraars Nederland indication form. On June 16, 2026, the company was fully acquired by Marksans Pharma (NSE: MARKSANS), a publicly listed Indian pharmaceutical company, serving as its European market entry vehicle alongside parallel subsidiary incorporations in Ireland and Canada.
QliniQ is led by Raymond Lansink (Representative) and operates with a lean team of 1-10 employees. The company is structured as a Dutch private limited company (B.V.) and is now a wholly-owned subsidiary of Marksans Pharma, with no institutional investment rounds prior to the strategic acquisition.
QliniQ firmographics
Firmographics- Name
- QliniQ
- Legal name
- QliniQ B.V.
- Website
- https://qliniqmedical.nl
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- QliniQ B.V. is a Dutch medical device and pharmaceutical distributor representing international manufacturers (VOE compression garments, Biodermis scar treatment, Stragen generics) for the Netherlands market through pharmacy wholesale, e-commerce, and insurance reimbursement channels.
- Ownership category
- akta.pro rank
QliniQ industry classification
Industry- Product category
- Medical device distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Medical, Dental & Lab Supply Marketplaces (CRAFAHAG)
- akta.pro secondary industry
- Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)
Keywords
Where QliniQ is headquartered
LocationHeadquarters
- HQ city
- Oldenzaal
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
QliniQ business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Marketing or Sales, Personnel, Others
Revenue model
- Medical device distribution: Distribution of medical devices including post-operative compression clothing and scar treatment products through pharmacies and direct sales in the Netherlands
- Pharmaceutical wholesale: Pharmaceutical wholesale distribution of generic medicines to pharmacies across the Netherlands, operating under GDP certification and pharmaceutical wholesale license obtained in 2016
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Biodermis products with insurance reimbursement |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
QliniQ product offering
Product offeringCore offering
QliniQ B.V. operates as a Netherlands-based distributor and representative of world-leading manufacturers of medical devices and medicines. The company distributes post-operative compression clothing (VOE brand), silicone scar treatment products (Biodermis brand), and generic pharmaceuticals (Farmaceuticals) to Dutch pharmacies and consumers through its own webshop and wholesale channels.
Product overview
QliniQ BV is a Dutch medical device and pharmaceutical distributor and wholesale supplier based in Oldenzaal, operating as a representative for several leading global manufacturers of medical devices and medicines. Its product portfolio spans three main categories: (1) VOE post-operative compression garments and VOE Slim slimming/shapewear garments with embedded active ingredients, distributed from Spain; (2) the Biodermis scar treatment line — including Xeragel (silicone gel), ProSil (silicone gel stick), and Epiderm (silicone sheets in multiple variants) — for treating hypertrophic and keloid scars; and (3) generic pharmaceuticals (Farmaceutische groothandel) including hormone tablets, topical creams, and diagnostic self-tests, distributed through Dutch pharmacy wholesalers. All products are manufactured within the EU, with the Netherlands, Germany, and Spain as primary production countries. The company is wholly owned by Marksans Pharma (acquired June 16, 2026).
Differentiator
Problem solved
Functional benefit
Brands
- VOE: Spanish post-operative compression clothing brand providing constant and long-lasting pressure for reduction of hematomas and swelling after various treatments.
- Biodermis
- Farmaceuticals
Products and services
- VOE Compression Clothing Post-operative compression garments manufactured by Spanish brand VOE, providing constant and prolonged pressure to reduce hematomas and swelling following surgical procedures such as liposuction, abdominoplasty, and mastopexy. Distributed to Dutch patients and consumers with custom-made orders fulfilled via in-house atelier.
- VOE Slim Slimming garments made from elastic material with thousands of microcapsules woven into the fabric, releasing active ingredients including Caffeine, Retinol, Vitamin A, Ceramides, Vitamin E, and Aloe Vera gradually into the skin during wear. Distributed as a VOE sub-brand in the Netherlands.
- Biodermis Scar Treatment Products Medical device line from Biodermis for preventing and treating hypertrophic and keloid scars. Includes Xeragel (100% silicone gel), Epiderm (silicone sheeting), and ProSil (silicone gel stick), distributed in the Netherlands and eligible for reimbursement through Dutch health insurers when prescribed with the proper indication form.
- QliniQ Farmaceuticals (Generic Medicines) Generic pharmaceutical products distributed under QliniQ's pharmaceutical wholesale license (held since January 2016 with GDP certification). Products include Tibolon Mithra tablets, Cortifil cream, Zarelle film-coated tablets, Vagirux, Triamcinolone acetonide ointment, Dienogest Stragen, and Fecotest diagnostic self-test, available through all pharmaceutical wholesalers in the Netherlands.
Companies that use QliniQ
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles3 records
QliniQ technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
QliniQ partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- StragencoreStragen is one of the world's leading manufacturers of medical devices and medicines represented by QliniQ B.V. in the Netherlands. QliniQ distributes Stragen products including Dienogest Stragen 2mg pharmaceutical product.
- VOEcoreVOE is a Spanish brand of post-operative compression clothing represented by QliniQ B.V. in the Netherlands. QliniQ distributes VOE compression garments known for providing constant and prolonged pressure to reduce hematomas and swelling.
- Basic PharmaminorBasic Pharma is one of the manufacturers of medical devices and medicines represented by QliniQ B.V. in the Netherlands market.
- CERES PharmaminorCERES Pharma is one of the manufacturers of medical devices and medicines represented by QliniQ B.V. in the Netherlands market.
- BiodermiscoreBiodermis is a global leader for over 20 years in scar treatment, represented by QliniQ B.V. in the Netherlands. Products include Xeragel (silicone gel), Epiderm (silicone sheeting), and ProSil (silicone gel stick) for hypertrophic and keloid scar treatment.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
QliniQ competitors and assessment
Company assessmentDirect peers
- Mediq: Major Dutch distributor of medical devices and healthcare supplies, serving pharmacies, hospitals, and patients. Closest direct comparable to QliniQ's medical device distribution business in the same Dutch market.
- Mölnlycke Health Care: Swedish wound care and scar management company offering Mepiform silicone scar sheets and other post-operative products. Directly competes with the Biodermis Epiderm line that QliniQ distributes and is a benchmark for the scar-treatment distribution space.
Regional players
- Eurocept Pharmaceuticals: Dutch specialty pharmaceutical company distributing niche and generic medicines through the Dutch pharmacy channel. Comparable to QliniQ's Farmaceuticals division and operates in the same domestic reimbursement environment.
Broad incumbents
- Hartmann Group: German-based manufacturer and distributor of medical products including wound care, compression therapy, and surgical supplies. Overlaps with QliniQ's VOE compression and Biodermis scar treatment categories at a much broader scale.
- ConvaTec: Global medical device company with a strong portfolio in advanced wound care, ostomy, and post-operative products. Comparable to QliniQ's portfolio positioning around post-surgical patient care.
- Coloplast: Danish medical device company specializing in ostomy, wound, and continence care products distributed through pharmacies and hospitals. Comparable to QliniQ as a broader medical device distributor in adjacent categories.
- Alliance Healthcare: European pharmaceutical wholesaler and distributor serving pharmacies across multiple countries. Comparable to QliniQ's pharmaceutical wholesale operations but at much greater scale and geographic reach.
- Smith & Nephew: Global medical technology company with advanced wound management products including silicone-based scar therapies. Direct overlap with QliniQ's Biodermis scar treatment franchise at a much larger scale.
- Phoenix Group: One of Europe's largest pharmaceutical distribution and wholesale groups, supplying pharmacies across the continent. Comparable to QliniQ's pharmaceutical wholesale stream as a large-scale channel peer.
- Sandoz: Global leader in generic pharmaceuticals and biosimilars. Comparable to QliniQ's generic pharmaceutical wholesale stream and representative of the upstream manufacturer dynamic that shapes QliniQ's procurement.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
QliniQ social profiles
Digital presenceQliniQ compliance and trust
Trust signalCompliance1 record
QliniQ financial estimates
Financial estimateRevenue estimate
Valuation estimate
QliniQ leadership team
Management profileNumber of profiles
Profiles1 record
QliniQ funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
QliniQ M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about QliniQ
What does QliniQ do?
QliniQ B.V. operates as a Netherlands-based distributor and representative of world-leading manufacturers of medical devices and medicines. The company distributes post-operative compression clothing (VOE brand), silicone scar treatment products (Biodermis brand), and generic pharmaceuticals (Farmaceuticals) to Dutch pharmacies and consumers through its own webshop and wholesale channels.
Is QliniQ a public or private company?
QliniQ is a private company. It is classified as corporate owned and is currently operating.
When was QliniQ founded?
QliniQ was founded in 2015. It employs 1 to 10 people.
Where is QliniQ based?
QliniQ is headquartered in Oldenzaal, Netherlands, in the Europe region.
How does QliniQ make money?
Two revenue lines are on record. Medical device distribution is the primary driver. The others are pharmaceutical wholesale.
Who are QliniQ's main competitors?
Direct peers on record are Mediq and Mölnlycke Health Care. Eurocept Pharmaceuticals is listed as a regional player. Broad incumbents are Hartmann Group, ConvaTec, Coloplast, Alliance Healthcare, Smith & Nephew, Phoenix Group and Sandoz.
Does QliniQ have an API?
No public API is recorded for QliniQ.
What industry is QliniQ in?
QliniQ's product category is Medical device distribution. Its primary akta.pro industry code is CRAFAHAG, Medical, Dental & Lab Supply Marketplaces, with a secondary code of HLAIAJAF, Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor). Its NAICS code is 424210 and its SIC code is 5122.